Nasseef Md Taufiq, Singh Jai Puneet, Ehrlich Aliza T, McNicholas Michael, Park Da Woon, Ma Weiya, Kulkarni Praveen, Kieffer Brigitte L, Darcq Emmanuel
Douglas Hospital Research Center, Department of Psychiatry, School of Medicine, McGill University, Montreal, Quebec H4H 1R3, Canada.
Center for Translational Neuro-Imaging, Northeastern University, Boston, Massachusetts 02115, United States.
ACS Pharmacol Transl Sci. 2019 Jun 28;2(4):264-274. doi: 10.1021/acsptsci.9b00021. eCollection 2019 Aug 9.
Oxycodone is a potent medicinal opioid analgesic to treat pain. It is also addictive and a main cause for the current opioid crisis. At present, the impact of oxycodone on coordinated brain network activities, and contribution of the mu opioid receptor (MOR) to these effects, is unknown. We used pharmacological magnetic resonance imaging in mice to characterize MOR-mediated oxycodone effects on whole-brain functional connectivity (FC). Control (CTL) and MOR knockout (KO) animals were imaged under dexmedetomidine in a 7Tesla scanner. Acquisition was performed continuously before and after 2 mg/kg oxycodone administration (analgesic in CTL mice). Independent component analysis (data-driven) produced a correlation matrix, showing widespread oxycodone-induced reduction of FC across 71 components. Isocortex, nucleus accumbens (NAc), pontine reticular nucleus, and periacqueducal gray (PAG) components showed the highest number of significant changes. Seed-to-voxel FC analysis (hypothesis-driven) was then focused on PAG and NAc considered key pain and reward centers. The two seeds showed reduced FC with 8 and 22 Allen Brain Atlas-based regions, respectively, in CTL but not KO mice. Further seed-to-seed quantification showed highest FC modifications of both PAG and NAc seeds with hypothalamic and amygdalar areas, as well as between them, revealing the strongest impact across reward and aversion/pain centers of the brain. In conclusion, we demonstrate that oxycodone reduces brain communication in a MOR-dependent manner, and establish a preliminary whole-brain FC signature of oxycodone. This proof-of-principle study provides a unique platform and reference data set to test other MOR opioid agonists and perhaps discover new mechanisms and FC biomarkers predicting safer analgesics.
羟考酮是一种强效的药用阿片类镇痛药,用于治疗疼痛。它也会上瘾,是当前阿片类药物危机的主要原因。目前,羟考酮对大脑协调网络活动的影响以及μ阿片受体(MOR)对这些影响的作用尚不清楚。我们在小鼠中使用药理磁共振成像来表征MOR介导的羟考酮对全脑功能连接(FC)的影响。在7特斯拉扫描仪中,对对照组(CTL)和MOR基因敲除(KO)动物在右美托咪定麻醉下进行成像。在给予2 mg/kg羟考酮(对CTL小鼠具有镇痛作用)之前和之后连续进行采集。独立成分分析(数据驱动)产生了一个相关矩阵,显示羟考酮诱导71个成分的FC广泛降低。等皮质、伏隔核(NAc)、脑桥网状核和导水管周围灰质(PAG)成分显示出最多的显著变化。然后,种子到体素的FC分析(假设驱动)集中在被认为是关键疼痛和奖赏中心的PAG和NAc上。在CTL小鼠而非KO小鼠中,这两个种子分别与8个和22个基于艾伦脑图谱的区域的FC降低。进一步的种子到种子定量显示,PAG和NAc种子与下丘脑和杏仁核区域以及它们之间的FC修饰最高,揭示了对大脑奖赏和厌恶/疼痛中心的最强影响。总之,我们证明羟考酮以MOR依赖的方式减少大脑通信,并建立了羟考酮的初步全脑FC特征。这项原理验证研究提供了一个独特的平台和参考数据集,以测试其他MOR阿片类激动剂,并可能发现预测更安全镇痛药的新机制和FC生物标志物。